Trial Profile
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ) Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 15 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Aug 2013 New trial record